The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Glutaminolysis: Supplying carbon or nitrogen or both for cancer cells?
Open accessAbstract
A cancer cell comprising largely of carbon, hydrogen, oxygen, phosphorus, nitrogen and sulfur requires not only glucose, which is avidly transported and converted to lactate by aerobic glycolysis or the Warburg effect, but also glutamine as a major substrate. Glutamine and essential amino acids, such as methionine, provide energy through the TCA cycle as well as nitrogen, sulfur and carbon skeletons for growing and proliferating cancer cells. The interplay between utilization of glutamine and glucose is likely to depend on the genetic make-up of a cancer cell. While the MYC oncogene induces both aerobic glycolysis and glutaminolysis, activated β-catenin induces glutamine synthesis in hepatocellular carcinoma. Cancer cells that have elevated glutamine synthetase can use glutamate and ammonia to synthesize glutamine and are hence not addicted to glutamine. As such, cancer cells have many degrees of freedom for re-programming cell metabolism, which with better understanding will result in novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glutamine serves as an anaplerosis substrate to fuel the TCA cycle for energy generation and also provides nitrogen for protein synthesis (Dang, 2010; Wise and Thompson, 2010; DeBerardinis and Cheng, 2010; Daye and Wellen, 2012; Gaglio et al., 2009; Johnson et al., 2003; Rajagopalan and DeBerardinis, 2011; Shanware et al., 2011; Weinberg et al., 2010).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Dang, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Research works printed but not linked: 5
- Baggetto LG. Deviant energetic metabolism of glyco- lytic cancer cells. Biochimie 1992; 74:959-74.
- Dang CV. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 2010; 70:859-62.
- Weinhouse S. Glycolysis, respiration and anoma- lous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture. Cancer Res 1972; 32:2007-16.
- Linder-Horowitz M, Knox WE, Morris HP. Glutaminase activities and growth rates of rat hepa- tomas. Cancer Res 1969; 29:1195-9.
- Kovacevic Z, Morris HP. The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 1972; 32:326-33.
Cited by
Sorted by citations
Items 201–245 of 245
Use of oral squamous cell carcinoma: A discussion paper
Senevirathna, K., Jayawardana, N. U., Gamage, C. U., Perera, A. G. U., Jayasinghe, R. D., & Seneviratne, B. (2023) · International Health Trends and Perspectives · doi:10.32920/ihtp.v3i1.1676 · Cited by 3
Ubiquitin–Proteasome System in the Hallmarks of Cancer
Bhattacharjee, P., Mazumdar, M., Guha, D., & Sa, G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9099-9_9 · Cited by 2
Back to the Future: Therapeutic Targeting of Cancer Cell Metabolism
Gilmour, R., & Velasco, S. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217691265 · Cited by 2
Thankappan, S., & Sherin, N. (2017) · Tropical Journal of Medical Research · doi:10.4103/tjmr.tjmr_28_16 · Cited by 2
Hu, Y., Xie, P., Li, J., Liu, R., Wang, H., Wang, Z., & Liu, C. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s603170 · Cited by 1
Effects of Hypoxia and HIF-1 on Glutamine Metabolism
刘, 梦. (2021) · Bioprocess · doi:10.12677/bp.2021.111001 · Cited by 1
Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer
Das, D., Karthik, N., & Taneja, R. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_16 · Cited by 1
Noakes, T. D., Kalamian, M., Seyfried, T. N., Mukherjee, P., D’Agostino, D. P., Arismendi-Morillo, G., Chinopoulos, C., Tettenborn, M., & Winters, N. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821617-0.00012-7 · Cited by 1
Introduction to Autophagy in Physiology and Pathophysiology
Tavassoly, I. (2015) · Springer theses · doi:10.1007/978-3-319-14962-2_1 · Cited by 1
L-[5-11C]-Glutamine and Metabolic Imaging in Cancer Cells
Plöessl, K., Lieberman, B. P., Choi, S., Zhu, L., & Kung, H. F. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_9 · Cited by 1
Metabolic Shunt Pathways, Carcinoma, and mTOR
Shibuya, N., Inoue, K.-I., & Kubota, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00022-0 · Cited by 2
Tumor-Induced Metabolism and T Cells Located in Tumor Environment
Iranparast, S., Tayebi, S., Ahmadpour, F., & Yousefi, B. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009620666200720010647 · Cited by 1
Weller, S. R., Burnell, J. E., Aho, B. M., Obeng, B., Ledue, E. L., Shim, J. K., Hess, S. T., & Gosse, J. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.509813 · Cited by 1
Siano, N. (2025) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/8brr-wk43 · Cited by 1
Wu, X. (2014) · Michigan State University Libraries · doi:10.25335/m5bj6z
Alves, M. J. F. (2014) · doi:10.11606/d.5.2014.tde-02122014-083743
Müller, I. (2014) · Figshare
Development of a Biosensor to Monitor Glioblastoma
Anglin, N.-M. A., Dede, A., Jones, T. R., & Rosales, C. A. (2013)
Estudo dos genes DICER1 e C8orf48 em formas familiares de bócio multinodular e cancro da tiróide
de Mestre, G., & Leite, D. V. (2013)
Chapter 9 L -(5- 11 C)-Glutamine and Metabolic Imaging in Cancer Cells
Plöessl, K., Lieberman, B. P., Choi, S., Zhu, L., & Kung, H. F. (2015)
Manipulating aktivated metabolism via mtorc1
Prestinary, I. V. H. (2013) · Journal of International Crisis and Risk Communication Research
Metabolic Feedback Control through H3K4 Demethylation
Soloveychik, M. (2016) · TSpace (University of Toronto)
Role of ammonium ions on the modulation of apoptosis in glutamine-starved cells
Abusneina, A. M. (2017) · Lu Zone Ul (Laurentian University)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
Metabolic Deregulations in Acute Myeloid Leukemia
Mossuz, P., Chevalier, S., & Mondet, J. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/imcac.1.2021.3
Uma visão estrutural sobre componentes do processo de adaptação metabólica de tumores
Ambrosio, A. L. B. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2018.tde-25022021-104637
DEVELOPMENT OF TOOLS FOR ATOM-LEVEL INTERPRETATION OF STABLE ISOTOPE-RESOLVED METABOLOMICS DATASETS
Jin, H. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.303
A Preclinical Model of Cutaneous Melanoma Based on Reconstructed Human EpidermisPreprint
Groeber-Becker, F. K., Leikeim, A., Wußmann, M., Schmidt, F. F., Neto, N. G. B., Benz, F., Tiltmann, K., Junger, C., Monaghan, M. G., & Schilling, B. (2022) · Research Square · doi:10.21203/rs.3.rs-1193450/v1
Ripka, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718212471.793565111
Alsiary, R., Katouah, H. A., Al-Amodi, H. S. A. B., & Al-Toub, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815080384123010007
Metabolic determinants of leukemia onset variability in genetically homogeneous AKR mice
Nam, H., Kim, D., Jin, X., & Park, S. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150257
Ketone body, as an emerging modulator of metabolic reprogramming and epigenetics in breast cancer.
Mehdikhani, F., Rajabi, S., Mohammadlou, M., Maresca, M., & Baharlou, R. (2025) · PubMed Central · doi:10.22038/ijbms.2025.84064.18185
Straub, M., Sigman, D. M., Auderset, A., Ollivier, J., Petit, B., Hinnenberg, B., Rubach, F., Oleynik, S., Vozenin, M., & Martínez-García, A. (2021) · Figshare · doi:10.6084/m9.figshare.14978065
Sun, H., Zhang, C., Zheng, Y., Liu, C., Wang, X., & Cong, X. (2022) · Figshare · doi:10.6084/m9.figshare.20364135
Molecular markers of gliomas : implications for diagnosis and new target therapies
Stefano, A. L. D. (2017) · theses.fr (ABES) · doi:10.70675/de3bc517z8083z4bf5za1b4z9c09b5970230
A proteomic approach for understanding the metabolic adaptations in non-small cell lung cancer
Martín-Bernabé, A. (2018) · theses.fr (ABES) · doi:10.70675/426e7b40z057az4326z8cfez7da3a5c12c7e
Stage-specific changes in the Krebs cycle network regulate human erythroid differentiation
Romano, M. (2018) · theses.fr (ABES) · doi:10.70675/4312681cz0207z4923zb100z879f8a73681c
Rôle du transporteur mitochondrial UCP2 dans la leucémie
Sancerni, T. (2019) · theses.fr (ABES) · doi:10.70675/c0f1a3a3z992az4717zb426z210e51dadf82
Tamrazi, B., Markowitz, A. L., Margol, A., Nelson, M. D., Krieger, M. D., Snuderl, M., Ji, J., Cen, S., Cotter, J., & Blüml, S. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag101
Cai, L., Jendrossek, V., Matschke, J., & Vega-Rubín-de-Celis, S. (2026) · International review of cytology · doi:10.1016/bs.ircmb.2026.07.005
Metabolic Analyses of Crosstalk between Pancreatic Stromal and Cancer Cells
Bhinderwala, F., Souchek, J. J., Chaika, N. V., Abdullatif, F., Singh, P. K., Powers, R., & Gebregiworgis, T. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c02205
Metadata
- Authors
- Dang, C. V.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Dang, Chi V.
- ORCID
- Dang, Chi V.
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2010-10
- Volume
- 9
- Issue
- 19
- Pages
- 3884-3886
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- OpenAlex
- W1986517285
- Cited by
- 245
- References
- 0
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 10 · 2022: 21 · 2021: 15 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 18 · 2016: 24 · 2015: 21 · 2014: 25 · 2013: 21 · 2012: 17
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Cycle (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- glutaminolysis, glutamine metabolism, cancer metabolism, aerobic glycolysis, Warburg effect, TCA cycle, MYC oncogene, β-catenin, glutamine synthetase, glutamine addiction, hepatocellular carcinoma, methionine, metabolic reprogramming, cancer therapy
- MeSH terms
- Amino Acids, Carbon, Citric Acid Cycle, Energy Metabolism, Glucose, Glutamine, Glycolysis, Humans, Neoplasms, Nitrogen, Proto-Oncogene Proteins c-myc, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
